×
Entrez Id:
959
Gene Symbol:
CD40LG
CD40LG
0.020
Biomarker
disease
LHGDN
Immunohistochemistry was used to examine expression of BCL2, BAX, P53, CD40 and CD40L in archival tissues of patients included in various treatment trials for transitional cell carcinoma (TCC) of the bladder.
12592374
2003
×
Entrez Id:
7248
Gene Symbol:
TSC1
TSC1
0.020
GeneticVariation
disease
LHGDN
Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder.
14633685
2003
×
Entrez Id:
8140
Gene Symbol:
SLC7A5
SLC7A5
0.010
AlteredExpression
disease
LHGDN
In conclusion, the detection of the active form of LAT1 protein would appear to be of value in informing the risk of progression in transitional cell carcinoma of the upper urinary tract.
17622555
2007
×
Entrez Id:
29767
Gene Symbol:
TMOD2
TMOD2
0.010
AlteredExpression
disease
LHGDN
Alterations in tropomyosin isoform expression in human transitional cell carcinoma of the urinary bladder.
15095301
2004
×
Entrez Id:
4316
Gene Symbol:
MMP7
MMP7
0.010
AlteredExpression
disease
LHGDN
However, the expression of MMP-7 in transitional cell carcinoma (TCC) of the urinary bladder has not been previously investigated.
12579270
2003
×
Entrez Id:
5465
Gene Symbol:
PPARA
PPARA
0.010
Biomarker
disease
LHGDN
A-FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells.
19115207
2009
×
Entrez Id:
4103
Gene Symbol:
MAGEA4
MAGEA4
0.010
AlteredExpression
disease
LHGDN
Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: a tissue microarray study.
12209610
2002
×
Entrez Id:
3135
Gene Symbol:
HLA-G
HLA-G
0.010
GeneticVariation
disease
LHGDN
HLA-G polymorphism and transitional cell carcinoma of the bladder in a Brazilian population.
18721275
2008
×
Entrez Id:
356
Gene Symbol:
FASLG
FASLG
0.010
AlteredExpression
disease
LHGDN
Human urinary bladder transitional cell carcinomas acquire the functional Fas ligand during tumor progression.
12651606
2003
×
Entrez Id:
302
Gene Symbol:
ANXA2
ANXA2
0.010
Biomarker
disease
LHGDN
These findings suggest that annexin 2 mediated fibrinolysis on the transitional cell carcinoma cells may play a role in inducing hemorrhagic disorder in vascular intimal carcinomatosis.
16524621
2007
×
Entrez Id:
2167
Gene Symbol:
FABP4
FABP4
0.010
Biomarker
disease
LHGDN
A-FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells.
19115207
2009
×
Entrez Id:
916
Gene Symbol:
CD3E
CD3E
0.010
AlteredExpression
disease
LHGDN
Expression of CD3 antigens in renal tubule epithelium and renal oncocytomas.
16308105
2005
×
Entrez Id:
598
Gene Symbol:
BCL2L1
BCL2L1
0.010
Biomarker
disease
LHGDN
Evaluation of cytotoxic effects induced by bcl-2 and bcl-xL antisense-oligodeoxynucleotides in normal urothelium and transitional cell carcinoma.
19020723
2008
×
Entrez Id:
29766
Gene Symbol:
TMOD3
TMOD3
0.010
AlteredExpression
disease
LHGDN
Alterations in tropomyosin isoform expression in human transitional cell carcinoma of the urinary bladder.
15095301
2004
×
Entrez Id:
3732
Gene Symbol:
CD82
CD82
0.010
AlteredExpression
disease
LHGDN
Expression of KAI1/CD82 and MRP-1/CD9 in transitional cell carcinoma of bladder.
17393117
2007
×
Entrez Id:
5329
Gene Symbol:
PLAUR
PLAUR
0.010
AlteredExpression
disease
LHGDN
We investigated uPA and uPAR gene expression in 20 human transitional cell carcinomas (TCC) of the bladder (n=19) and the renal pelvis (n=1) in comparison with adjacent non-malignant tissues.
15375521
2004
×
Entrez Id:
6469
Gene Symbol:
SHH
SHH
0.010
Biomarker
disease
LHGDN
Hedgehog signaling in normal urothelial cells and in urothelial carcinoma cell lines.
15521068
2005
×
Entrez Id:
928
Gene Symbol:
CD9
CD9
0.010
AlteredExpression
disease
LHGDN
Expression of KAI1/CD82 and MRP-1/CD9 in transitional cell carcinoma of bladder.
17393117
2007
×
Entrez Id:
7111
Gene Symbol:
TMOD1
TMOD1
0.010
AlteredExpression
disease
LHGDN
Alterations in tropomyosin isoform expression in human transitional cell carcinoma of the urinary bladder.
15095301
2004
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
0.530
CausalMutation
disease
CGI
×
Entrez Id:
595
Gene Symbol:
CCND1
CCND1
0.560
Biomarker
disease
CTD_human
Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors.
12151359
2002
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
0.530
Biomarker
disease
CTD_human
Enhanced expression of Harvey-ras oncogene in FANFT-induced transitional cell carcinoma.
3433577
1987
×
Entrez Id:
2261
Gene Symbol:
FGFR3
FGFR3
0.400
Biomarker
disease
CTD_human
Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation.
24121792
2013
×
Entrez Id:
7157
Gene Symbol:
TP53
TP53
0.400
Biomarker
disease
CTD_human
Specific-mutational patterns of p53 gene in bladder transitional cell carcinoma among a group of Iraqi patients exposed to war environmental hazards.
22929185
2012
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
0.350
Biomarker
disease
CTD_human
Expression of cycloxygenase-2 in human bladder and renal cell carcinoma.
12664575
2002